Rule 10b-5

The breadth of this language is intentional. Congress deliberately chose open-ended terms — manipulative or deceptive device or contrivance — rather than enumerating specific prohibited practices, granting the SEC authority to promulgate rules addressing the full range of fraudulent conduct that might evolve in securities markets over time without requiring Congressional amendment for each new category of fraud. Section 10(b) itself does not prohibit anything directly — it authorises the SEC to do so through rulemaking. Rule 10b-5 is the rule the SEC promulgated to exercise that authority.

Rule 10b-5 was adopted by the SEC on May 21, 1942, in a process that lasted approximately thirty minutes. The Commission had received information that the president of a Boston company was spreading false rumours about the company's performance to depress its stock price and purchase shares cheaply — conduct that violated the spirit of the Securities Exchange Act but fell outside any existing provision. Milton Freeman, the SEC attorney who drafted the rule, modelled it closely on Section 17(a) of the Securities Act of 1933, extending equivalent antifraud protections to the purchase as well as the sale of securities, since Section 17(a) covered only offers and sales. What was drafted in half an hour that morning has since become the most consequential single rule in the history of United States securities regulation.

The Text of Rule 10b-5 — Three Prohibitions

Rule 10b-5 states in full that it shall be unlawful for any person, directly or indirectly, by the use of any means or instrumentality of interstate commerce, or of the mails or of any facility of any national securities exchange, to engage in any of the following three categories of conduct in connection with the purchase or sale of any security.

Subsection (a) prohibits employing any device, scheme, or artifice to defraud. This catch-all prohibition addresses the widest range of fraudulent schemes — market manipulation, fraudulent inducement of securities transactions, pump and dump schemes, and any other structured deceptive activity designed to profit at the expense of counterparties. No specific misrepresentation is required — a scheme that operates to defraud through deceptive conduct rather than through affirmative false statements falls within subsection (a).

Subsection (b) prohibits making any untrue statement of a material fact or omitting to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading. This provision is the most frequently litigated of the three — it is the basis for securities fraud claims arising from false or misleading financial statements, earnings guidance, press releases, SEC filings, analyst calls, and any other written or oral communications about publicly traded companies. The critical elements are materiality and the misleading standard — omissions are actionable not when they merely involve silence about material facts in the abstract, but when the statements actually made are rendered misleading by what is left unsaid.

Subsection (c) prohibits engaging in any act, practice, or course of business which operates or would operate as a fraud or deceit upon any person. This provision extends the antifraud prohibition beyond discrete transactions to patterns of conduct — a series of individually non-fraudulent acts that collectively constitute a deceptive course of business falls within subsection (c) even if no single act rises to the level of a device, scheme, or misstatement actionable under subsections (a) or (b).

The Elements of a Rule 10b-5 Violation

For the SEC or a private plaintiff to establish a Rule 10b-5 violation, specific elements must each be proven. The full list of elements applicable to private plaintiffs is more demanding than what the SEC must establish in an administrative or civil enforcement action.

Manipulation or Deception

A misrepresentation, omission, or deceptive act is the foundational element. The Supreme Court held in Macquarie Infrastructure Corp. v. Moab Partners, L.P. — decided April 12, 2024 — that a pure omission of information required to be disclosed under Regulation S-K Item 303 does not by itself support a private Rule 10b-5(b) claim absent an affirmative statement rendered misleading by the omission. There is generally no duty to speak — a company that remains silent about a material fact has not violated Rule 10b-5(b) unless that silence renders some affirmative statement it has made false or misleading. Specific duties to disclose do arise in particular contexts — a corporate insider trading on material nonpublic information has a duty to either disclose that information or abstain from trading, as established by the classical insider trading theory.

Materiality

A misstatement or omission is material if there is a substantial likelihood that a reasonable investor would consider it important in making an investment decision — the standard established by the Supreme Court in TSC Industries, Inc. v. Northway, Inc., 426 U.S. 438 (1976) and extended to Rule 10b-5 cases in Basic Inc. v. Levinson, 485 U.S. 224 (1988). The Basic Court further held that for uncertain future events — such as preliminary merger discussions — materiality depends on the probability that the event will occur and the magnitude of its impact if it does, with both factors weighed together rather than either serving as a bright-line threshold.

Materiality is a fact-intensive determination made from the perspective of a reasonable investor, not from the perspective of the defendant or of any particular investor. Information that a company considers immaterial because it believes the market will not react may nonetheless be material under the reasonable investor standard if a reasonable investor would consider it important. Conversely, even accurate information may be immaterial if it concerns matters too trivial or speculative to alter the total mix of information available to reasonable investors.

Scienter

Scienter — the mental state element — requires proof that the defendant acted with a state of mind embracing intent to deceive, manipulate, or defraud, as established by the Supreme Court in Ernst and Ernst v. Hochfelder, 425 U.S. 185 (1976). The Hochfelder Court held that mere negligence — even gross negligence — is insufficient to establish a Rule 10b-5 violation. The defendant must have acted intentionally or with a level of recklessness that constitutes an extreme departure from ordinary standards of care — what courts call severe recklessness or conscious disregard of a known risk of misleading investors.

The scienter requirement is one of the most significant differences between Rule 10b-5 and Section 17(a) of the Securities Act — Section 17(a)(2) and (3) can be violated through negligent conduct, while Rule 10b-5 requires at minimum severe recklessness. This distinction has important practical consequences for SEC enforcement and private litigation — the SEC may bring Section 17(a) cases against negligent actors who could not be reached under Rule 10b-5.

The Private Securities Litigation Reform Act of 1995 — enacted in response to perceived abusive securities class action litigation — heightened the pleading standard for scienter in private Rule 10b-5 actions, requiring that plaintiffs plead with particularity facts giving rise to a strong inference of scienter before discovery is permitted. This heightened pleading requirement significantly reduced the volume of securities class action litigation and required plaintiffs to allege specific contemporaneous facts — internal communications, unusual trading patterns, or other concrete indicia of fraudulent intent — rather than merely alleging that the defendant knew or should have known their statements were false.

Connection With the Purchase or Sale of a Security

The in connection with requirement extends Rule 10b-5's reach to any deceptive conduct that touches upon the purchase or sale of a security — interpreted very broadly by both the SEC and federal courts. The in connection with element does not require that the fraud occur in the actual purchase or sale transaction itself — it requires only that the fraudulent conduct be sufficiently related to a securities transaction. The Supreme Court in SEC v. Zandford, 535 U.S. 813 (2002) held that a broker who misappropriated customer funds while selling customer securities had acted in connection with the purchase or sale of securities even though the misappropriation occurred through a series of separate transactions.

Reliance

For private plaintiffs — as distinguished from SEC enforcement actions, which do not require proof of reliance — reliance provides the causal connection between the defendant's misrepresentation and the plaintiff's investment decision. In cases involving affirmative misstatements, the plaintiff must establish that they actually relied on the false statement in making their investment decision. Requiring each plaintiff in a securities class action to individually prove actual reliance on a specific misstatement would make class certification practically impossible — each plaintiff would have independent reliance questions overwhelming the common issues required for class treatment.

The Supreme Court's decision in Basic Inc. v. Levinson, 485 U.S. 224 (1988) resolved this problem by adopting the fraud-on-the-market theory as the basis for a rebuttable presumption of reliance. Basic held that in an efficient securities market, material public information is rapidly incorporated into the market price of a security — the efficient capital markets hypothesis. A plaintiff who trades a security at the market price in an efficient market is relying on the integrity of that price, which itself reflects all publicly available material information. A material misrepresentation that distorts the market price therefore defrauds all investors who trade at that distorted price — even those who never read the specific misrepresentation — because they rely on the market price as an accurate reflection of public information.

The fraud-on-the-market presumption of reliance is rebuttable — defendants may establish that the alleged misrepresentation did not affect the market price, that the plaintiff was unaware of the misrepresentation's existence, or that the plaintiff would have traded regardless of knowing the truth. The Supreme Court in Halliburton Co. v. Erica P. John Fund, Inc., 573 U.S. 258 (2014) — Halliburton II — held that defendants may rebut the presumption at the class certification stage by introducing evidence that the alleged misrepresentation had no price impact, allowing class certification to be defeated before merits discovery when the defendant can demonstrate that the market price was not in fact distorted by the alleged fraud.

For omissions rather than affirmative misstatements, reliance is presumed — the plaintiff need not prove actual reliance on the omitted information because there is nothing to have read or relied upon directly.

Standing — The Purchaser-Seller Requirement

Private plaintiffs must be actual purchasers or sellers of the security to have standing under Rule 10b-5. The Supreme Court established this purchaser-seller requirement in Blue Chip Stamps v. Manor Drug Stores, 421 U.S. 723 (1975), holding that plaintiffs who claim they were fraudulently induced to forego purchasing or selling a security do not have standing regardless of the economic injury they suffered. The Blue Chip Stamps standing requirement has significantly limited the scope of private Rule 10b-5 litigation by excluding potential plaintiffs who were harmed by a fraud but did not actually transact in the security.

The purchaser-seller requirement does not limit the SEC, which may bring civil enforcement actions against individuals who engaged in fraudulent conduct in connection with securities transactions regardless of whether the SEC itself purchased or sold securities.

Loss Causation and Damages

Private plaintiffs must also prove loss causation — that the defendant's misrepresentation caused the plaintiff's economic loss — as distinguished from transaction causation — that the fraud caused them to enter the transaction. Loss causation requires demonstrating that the revelation of the fraud's truth caused the price decline that harmed the plaintiff, not that some unrelated market or company-specific development caused the loss. The Supreme Court addressed loss causation in Dura Pharmaceuticals, Inc. v. Broudo, 544 U.S. 336 (2005), holding that plaintiffs must plead and prove that the alleged fraud caused the economic loss — simply pleading that the plaintiff purchased at an inflated price is insufficient if the price declined for reasons unrelated to the disclosure of the fraud.

Rule 10b-5 and Insider Trading

The most extensively litigated and publicly prominent application of Rule 10b-5 is insider trading — the purchase or sale of securities while in possession of material nonpublic information in breach of a duty of trust or confidence. Two distinct theories of insider trading liability under Rule 10b-5 have been recognised by the Supreme Court.

The classical theory of insider trading liability — established in Chiarella v. United States, 445 U.S. 222 (1980) — holds that corporate insiders including officers, directors, and employees who trade their company's securities while in possession of material nonpublic information breach their fiduciary duty to the shareholders from whom they are purchasing or to whom they are selling, satisfying the deception element of Rule 10b-5. The classical theory is based on the insider's duty to disclose information to shareholders before trading — the abstain or disclose rule — arising from the relationship of trust and confidence between corporate insiders and shareholders.

The misappropriation theory — recognised by the Supreme Court in United States v. O'Hagan, 521 U.S. 642 (1997) — extends Rule 10b-5 insider trading liability to outsiders who are not corporate insiders of the company whose securities they trade but who misappropriate material nonpublic information by trading on it in breach of a duty of trust or confidence owed to the source of the information. A lawyer who learns of a planned acquisition from their corporate client and trades in the target's securities before the announcement has misappropriated confidential information from the source — the law firm and its client — and violated Rule 10b-5 through that misappropriation even though they owed no fiduciary duty to the target's shareholders. The misappropriation theory dramatically expanded the scope of insider trading liability beyond traditional corporate insiders to anyone who obtains material nonpublic information through a relationship of trust or confidence and trades on it.

Tippee liability — the liability of persons who receive tips of material nonpublic information from insiders and trade on them — was addressed by the Supreme Court in Dirks v. SEC, 463 U.S. 646 (1983). Dirks established that a tippee violates Rule 10b-5 only if the tipper breached a fiduciary duty in making the disclosure and the tippee knew or should have known of that breach. The tipper breaches a fiduciary duty only when they receive a personal benefit from the disclosure — either a direct financial benefit, a reputational benefit, or the benefit of making a gift of the information to a trading relative or friend. A tipper who discloses information for a legitimate business purpose or without receiving any personal benefit has not breached a duty, and a tippee who trades on such a disclosure does not violate Rule 10b-5.

The Insider Trading Sanctions Act of 1984 and the Insider Trading and Securities Fraud Enforcement Act of 1988 substantially strengthened the enforcement framework for insider trading — authorising civil penalties of up to three times the profit gained or loss avoided, providing express private rights of action for contemporaneous traders on the other side of illegal insider trading, and extending liability to controlling persons such as broker-dealers and investment advisers who fail to take adequate steps to prevent insider trading by persons under their control.

Rule 10b5-1 — The Pre-Planned Trading Safe Harbour

SEC Rule 10b5-1 — adopted in 2000 and significantly amended in December 2022 — addresses the specific question of when corporate insiders may trade their company's securities through pre-planned arrangements without violating the insider trading prohibition of Rule 10b-5. Prior to Rule 10b5-1, courts were divided on whether insider trading liability required that the insider actually use the material nonpublic information in making the trading decision, or whether mere possession of the information at the time of trading was sufficient.

Rule 10b5-1(b) resolved this issue by adopting an awareness standard — a trade is made on the basis of material nonpublic information if the person making the trade was aware of the information at the time. This awareness standard makes insider trading liability attach to trading while aware of material nonpublic information, regardless of whether the insider subjectively relied on that information. Rule 10b5-1(c) provides an affirmative defence for insiders who entered into trading plans before becoming aware of the material nonpublic information — the plan must specify the amount, price, and timing of trades in advance, and the insider must not exercise any subsequent influence over how, when, or whether the plan executes.

The December 2022 amendments — effective February 27, 2023 — substantially tightened the Rule 10b5-1 safe harbour in response to evidence that many insiders were using it opportunistically. The amendments require a cooling-off period between the adoption of a 10b5-1 plan and the first trade — ninety days for officers and directors, subject to a 120-day maximum, and thirty days for other insiders. They require directors and officers to certify that they are not aware of material nonpublic information when adopting the plan. They limit officers and directors to a single active 10b5-1 plan at a time — eliminating the practice of maintaining multiple plans and selectively cancelling those that become unfavourable. And they require single-trade plans to be used only once per twelve-month period.

SEC Enforcement — Civil and Criminal Penalties

The SEC is the primary federal regulator responsible for investigating and bringing civil enforcement actions for Rule 10b-5 violations through its Division of Enforcement. The SEC may bring civil enforcement actions in federal district court seeking injunctive relief, disgorgement of profits, payment of prejudgment interest, and civil money penalties. The SEC may also initiate administrative proceedings before an Administrative Law Judge to suspend or revoke the registration of broker-dealers, investment advisers, and associated persons who have violated Rule 10b-5.

Civil penalties for Rule 10b-5 violations in insider trading cases under Section 21A of the Exchange Act reach up to the greater of three times the profit gained or loss avoided or a specified dollar amount adjusted for inflation. Civil money penalties in non-insider-trading fraud cases reach specified statutory maximums that have been adjusted upward multiple times to maintain their deterrent effect.

Wilful violations of Rule 10b-5 may also be prosecuted as criminal offences under Section 32(a) of the Exchange Act — the wilfulness requirement distinguishes criminal from civil liability and requires proof that the defendant knew their conduct was unlawful. Criminal penalties for wilful violations include imprisonment of up to twenty years and fines of up to five million dollars for individuals. These criminal penalties are prosecuted by the Department of Justice rather than the SEC, typically through the securities and commodities fraud units of United States Attorney's Offices in major financial centres.

The Private Right of Action — Judicially Implied

Unlike Section 11 of the Securities Act of 1933 and other provisions that expressly create private rights of action, Rule 10b-5 contains no explicit authorisation for private suits. Federal courts first implied a private right of action under Rule 10b-5 in the early 1940s and 1950s, and the Supreme Court ultimately confirmed its existence in Superintendent of Insurance v. Bankers Life and Casualty Co., 404 U.S. 6 (1971), holding that a private right of action exists under Section 10(b) and Rule 10b-5. The implied private right of action under Rule 10b-5 has since generated more securities litigation than any other provision of federal securities law — Rule 10b-5 claims appear in the overwhelming majority of securities class action complaints filed annually.

Private plaintiffs have additional elements to prove beyond what the SEC must establish — standing as actual purchasers or sellers under Blue Chip Stamps, reliance or its presumed equivalent under Basic, loss causation under Dura Pharmaceuticals, and actual damages. These additional elements reflect the Supreme Court's repeated efforts to cabin the scope of private Rule 10b-5 litigation without eliminating the private enforcement mechanism that supplements SEC resources in policing securities markets.

The Scope of Rule 10b-5 — Any Person, Any Security, Any Transaction

Three features of Rule 10b-5's scope are particularly important and directly tested on securities licensing examinations.

Rule 10b-5 applies to any person — not just registered broker-dealers, investment advisers, corporate insiders, or other regulated entities. Any individual who uses interstate commerce or the mails in connection with a fraudulent securities transaction may violate Rule 10b-5 — a corporate investor, an individual trader, a lawyer, a journalist, or any other person who trades on misappropriated information or makes material misrepresentations in connection with securities transactions.

Rule 10b-5 applies to any security — both registered and unregistered securities, both exchange-listed and OTC securities, both equity and debt securities, both domestic and foreign securities traded in US markets. Unlike the Securities Act of 1933, which applies primarily to registered public offerings, Rule 10b-5's reach extends to private placements, restricted securities, and any other securities transaction effected through interstate commerce.

Rule 10b-5 applies to both purchases and sales — unlike Section 17(a) of the Securities Act, which covers only offers and sales. This bilateral coverage is what makes Rule 10b-5 the appropriate vehicle for prosecuting insider trading on the purchase side — a corporate insider who purchases their company's stock before announcing positive earnings results on the basis of material nonpublic information can be prosecuted under Rule 10b-5 even though Section 17(a) would not apply.

Examination Relevance and Key Takeaways

Rule 10b-5 is tested on the Series 7 and Series 65 examinations in the context of securities fraud, insider trading, material misrepresentation, the elements of a violation, the distinction between classical and misappropriation insider trading theory, and the enforcement framework.

The key points to retain are these.

Rule 10b-5 — 17 CFR Section 240.10b-5 — was adopted May 21, 1942 under Section 10(b) of the Securities Exchange Act of 1934, which authorises the SEC to prohibit manipulative or deceptive devices in connection with securities transactions. Rule 10b-5 contains three prohibitions — subsection (a) device, scheme, or artifice to defraud; subsection (b) material misstatement or misleading omission; and subsection (c) fraudulent act, practice, or course of business — each applicable to any person, any security, and both purchases and sales effected through interstate commerce.

The elements of a Rule 10b-5 violation for private plaintiffs are manipulation or deception, materiality — substantial likelihood a reasonable investor would consider the information important, established in TSC Industries v. Northway 426 U.S. 438 (1976) and Basic Inc. v. Levinson 485 U.S. 224 (1988) — scienter — intent to deceive or severe recklessness established in Ernst and Ernst v. Hochfelder 425 U.S. 185 (1976), with heightened pleading under the PSLRA 1995 — in connection with the purchase or sale of a security, standing as an actual purchaser or seller under Blue Chip Stamps 421 U.S. 723 (1975), reliance or its presumed equivalent under the fraud-on-the-market doctrine from Basic, loss causation under Dura Pharmaceuticals 544 U.S. 336 (2005), and damages.

Insider trading under Rule 10b-5 operates through two theories — the classical theory requiring a fiduciary duty to shareholders by corporate insiders who trade on material nonpublic information, established in Chiarella v. United States 445 U.S. 222 (1980); and the misappropriation theory covering outsiders who breach a duty of trust to the source of the information, established in United States v. O'Hagan 521 U.S. 642 (1997). Tippee liability requires that the tipper breached a duty for personal benefit and the tippee knew or should have known of the breach, established in Dirks v. SEC 463 U.S. 646 (1983). Rule 10b5-1 provides an affirmative defence for pre-planned trading arrangements entered before awareness of material nonpublic information — with the December 2022 amendments requiring cooling-off periods, single active plans, and certifications of no MNPI awareness for officers and directors. Civil penalties reach three times profits under Section 21A. Criminal penalties under Section 32(a) reach twenty years imprisonment and five million dollars for wilful violations.